Yes, sotatercept is a new medication being tested for pulmonary arterial hypertension (PAH). It works by capturing specific proteins in the body, helping to balance growth signals and reduce inflammation. This improves blood flow in the lungs and makes it easier for the heart to pump blood. Sotatercept is administered as a Show Full Answer

Yes, sotatercept is a new medication being tested for pulmonary arterial hypertension (PAH). It works by capturing specific proteins in the body, helping to balance growth signals and reduce inflammation. This improves blood flow in the lungs and makes it easier for the heart to pump blood. Sotatercept is administered as a subcutaneous injection once every three weeks. In trials, it has shown significant improvements in pulmonary vascular resistance and the ability to walk.

 This AI-generated response comes from myPHteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

New Pulmonary Arterial Hypertension Medications: 4 Advances in Treatment | myPHteam

Researchers Explore a New Type of Therapy To Treat PAH | myPHteam